Tilray Brands (TLRY) Asset Writedowns and Impairment (2017 - 2025)

Tilray Brands (TLRY) posted Asset Writedowns and Impairment of -$699.2 million for Q2 2025, down 200.0% on a QoQ basis from $699.2 million in Q1 2025.

Tilray Brands (TLRY) Asset Writedowns and Impairment (2017 - 2025) Analysis & Trends

Tilray Brands' Asset Writedowns and Impairment history runs 8 years deep, the most recent figure standing at -$699.2 million for Q2 2025.

  • Quarterly Asset Writedowns and Impairment changed N/A year-over-year to -$699.2 million in Q2 2025, while the trailing twelve-month figure through Feb 2025 was $1.6 billion (down 27.58% YoY) and the FY2023 annual result came in at $934.0 million, up 146.93% from the prior year.
  • Asset Writedowns and Impairment was -$699.2 million for Q2 2025 at Tilray Brands, down from $699.2 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $934.0 million in Q1 2023 and bottomed at -$699.2 million in Q2 2025.
  • A 4-year average of $363.1 million and a median of $532.7 million in 2022 frame the typical range for Asset Writedowns and Impairment.
  • Annual changes were most pronounced in 2021 — Asset Writedowns and Impairment sank 105.43% — and 2022, when it surged 45595.78%.
  • Tilray Brands' Asset Writedowns and Impairment stood at -$805000.0 in 2021, then jumped by 45595.78% to $366.2 million in 2022, then surged by 140.01% to $879.0 million in 2023, then tumbled by 179.55% to -$699.2 million in 2025.
  • Business Quant data shows TLRY's Asset Writedowns and Impairment at -$699.2 million in Q2 2025, $699.2 million in Q1 2025, and $879.0 million in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Tilray Brands 465.02 Mn 373.06 Mn 54.95 Mn

Historic Data

Download Data
DateValue
May 31, 2025 -699.24 Mn
May 31, 2025 -699.24 Mn
Feb 28, 2025 699.24 Mn
Feb 28, 2025 699.24 Mn
May 31, 2023 879.00 Mn
May 31, 2023 879.00 Mn
Feb 28, 2023 934.00 Mn
Feb 28, 2023 934.00 Mn
May 31, 2022 366.24 Mn
May 31, 2022 366.24 Mn
May 31, 2021 -805,000.00
May 31, 2021 -805,000.00
May 31, 2020 14.82 Mn
May 31, 2020 14.82 Mn
Mar 31, 2020 46,000.00
Mar 31, 2020 46,000.00
Sep 30, 2019 -275,000.00
Sep 30, 2019 -275,000.00
May 31, 2019 57.19 Mn
May 31, 2019 57.19 Mn